Literature DB >> 22078457

Neurologic considerations in propionic acidemia.

John Schreiber1, Kimberly A Chapman, Marshall L Summar, Nicholas Ah Mew, V Reid Sutton, Erin MacLeod, Kathy Stagni, Keiko Ueda, Jill Franks, Eddie Island, Dietrich Matern, Loren Peña, Brittany Smith, Tiina Urv, Charles Venditti, Anupam Chakarapani, Andrea L Gropman.   

Abstract

Propionic acidemia (PA) is an organic acidemia which has a broad range of neurological complications, including developmental delay, intellectual disability, structural abnormalities, metabolic stroke-like episodes, seizures, optic neuropathy, and cranial nerve abnormalities. As the PA consensus conference hosted by Children's National Medical Center progressed from January 28 to 30, 2011, it became evident that neurological complications were common and a major component of morbidity, but the role of imaging and the basis for brain pathophysiology were unclear. This paper reviews the hypothesized pathophysiology, presentation and uses the best available evidence to suggest programs for treatment, imaging, and monitoring the neurological complications of PA.
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22078457     DOI: 10.1016/j.ymgme.2011.10.003

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  24 in total

1.  Impact of age at onset and newborn screening on outcome in organic acidurias.

Authors:  Jana Heringer; Vassili Valayannopoulos; Allan M Lund; Frits A Wijburg; Peter Freisinger; Ivo Barić; Matthias R Baumgartner; Peter Burgard; Alberto B Burlina; Kimberly A Chapman; Elisenda Cortès I Saladelafont; Daniela Karall; Chris Mühlhausen; Victoria Riches; Manuel Schiff; Jolanta Sykut-Cegielska; John H Walter; Jiri Zeman; Brigitte Chabrol; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2015-12-21       Impact factor: 4.982

2.  Autism spectrum disorder in a child with propionic acidemia.

Authors:  M Al-Owain; N Kaya; H Al-Shamrani; A Al-Bakheet; A Qari; S Al-Muaigl; M Ghaziuddin
Journal:  JIMD Rep       Date:  2012-03-31

3.  Gut microbiota: Intestinal bacteria influence brain activity in healthy humans.

Authors:  Stephen M Collins; Premsyl Bercik
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-07       Impact factor: 46.802

Review 4.  Irritable bowel syndrome: a gut microbiota-related disorder?

Authors:  Yogesh Bhattarai; David A Muniz Pedrogo; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-23       Impact factor: 4.052

Review 5.  Propionyl-CoA carboxylase - A review.

Authors:  Parith Wongkittichote; Nicholas Ah Mew; Kimberly A Chapman
Journal:  Mol Genet Metab       Date:  2017-10-07       Impact factor: 4.797

6.  Expansion of the Phenotypic Spectrum of Propionic Acidemia with Isolated Elevated Propionylcarnitine.

Authors:  Gerarda Cappuccio; Paldeep S Atwal; Taraka R Donti; Kiki Ugarte; Nadia Merchant; William J Craigen; V Reid Sutton; Sarah H Elsea
Journal:  JIMD Rep       Date:  2016-11-30

Review 7.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

Review 8.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

9.  Propionic acidemia and optic neuropathy: a report of two cases.

Authors:  Carolina Arias; Erna Raimann; Pilar Peredo; Juan Francisco Cabello; Gabriela Castro; Alf Valiente; Alicia de la Parra; Paulina Bravo; Cecilia Okuma; Verónica Cornejo
Journal:  JIMD Rep       Date:  2013-07-02

10.  Association of microbiota-derived propionic acid and Alzheimer's disease; bioinformatics analysis.

Authors:  Morteza Aliashrafi; Mohammad Nasehi; Mohammad-Reza Zarrindast; Mohammad Taghi Joghataei; Hakimeh Zali; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2020-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.